| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/05/2011 | WO2010151751A3 Heat-treated limulus amebocyte lysates |
| 05/05/2011 | WO2010146059A3 Biomarkers for igf-1r inhibitor therapy |
| 05/05/2011 | WO2010047938A3 Mmp activation peptide detection in biological samples |
| 05/05/2011 | WO2010006333A3 Quantification of enzyme activity by mass spectrometry using immobilized substrates |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110107439 Diagnostic of pre-symptomatic metabolic syndrome |
| 05/05/2011 | US20110106453 Method for storing a series of measurements |
| 05/05/2011 | US20110106448 Database System and Method of Obtaining and Communicating Data |
| 05/05/2011 | US20110105935 Ventilation analysis and monitoring |
| 05/05/2011 | US20110105741 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105587 Target sequences and methods to identify the same, useful in treatment of neurodegenerative diseases |
| 05/05/2011 | US20110105554 Means for treating myosin-related diseases |
| 05/05/2011 | US20110105539 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists |
| 05/05/2011 | US20110105529 ERCC-1 Gene Expression Predicts Chemotherapy Outcome |
| 05/05/2011 | US20110105467 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype |
| 05/05/2011 | US20110105415 Gene regulator |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105383 Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| 05/05/2011 | US20110105365 Pro-epil expression level in a biological sample as testicular cancer biomarker, particularly in combination with the hcbeta and afp biomarkers |
| 05/05/2011 | US20110105354 Methods and Apparatus for Conducting Multiple Measurements on a Sample |
| 05/05/2011 | US20110105353 Fetal Genomic Analysis From A Maternal Biological Sample |
| 05/05/2011 | US20110105349 Use of a monophosphate ester of a phthalein compound as a substrate for tartrate-resistant acid phosphatase b5 (trap 5b) |
| 05/05/2011 | US20110105348 Method for detecting an analyte in a sample |
| 05/05/2011 | US20110104826 Calibration of fluidic devices |
| 05/05/2011 | US20110104825 Method for enhancing sensitivity or method for avoiding influence of hemoglobin in immunological measurement |
| 05/05/2011 | US20110104823 Measuring lipoprotein containing particles |
| 05/05/2011 | US20110104822 Determination of Distribution |
| 05/05/2011 | US20110104821 ABeta-OLIGOMER MEASUREMENT METHOD |
| 05/05/2011 | US20110104820 Tyrosine, Serine, And Threonine Phosphorylation Sites |
| 05/05/2011 | US20110104819 Modification of Bioassays for Detection of Antigens Characteristic of Bacteria that are Causative of Ear and Respiratory Infections to Eliminate False Positive Results Caused by Nasopharyngeal Colonization of Children |
| 05/05/2011 | US20110104818 Carbamylated proteins and risk of cardiovascular disease |
| 05/05/2011 | US20110104817 Integrated micro device, a method for detecting biomarkers using the integrated micro device, a method for manufacturing an integrated micro device, and an integrated micro device arrangement |
| 05/05/2011 | US20110104814 Heparan sulfate glycosaminoglycan lyase and uses thereof |
| 05/05/2011 | US20110104813 Diagnosis of early stage cardiac dysfunction |
| 05/05/2011 | US20110104812 Process for treating polymers containing residual catalyst |
| 05/05/2011 | US20110104809 Downhole spectroscopic hydrogen sulfide detection |
| 05/05/2011 | US20110104807 Method for quantifying permanganate-reducing compounds |
| 05/05/2011 | US20110104755 Antibodies immunoreactive with mutant hydroxypenylpyruvatedioxygenase |
| 05/05/2011 | US20110104740 Fluorescent protein and chromoprotein |
| 05/05/2011 | US20110104739 Biomarkers for amyotrophic lateral sclerosis |
| 05/05/2011 | US20110104737 Photometric measuring method for a sample liquid, a photometric measuring device, and a mixing container for a photometric measuring device |
| 05/05/2011 | US20110104735 Human omental mesothelial cells, methods of isolation and uses thereof |
| 05/05/2011 | US20110104726 Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome |
| 05/05/2011 | US20110104725 Method of Effecting Coagulation in a Droplet |
| 05/05/2011 | US20110104724 Biomarkers of mild cognitive impairment and alzheimer's disease |
| 05/05/2011 | US20110104723 Biomarkers |
| 05/05/2011 | US20110104722 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2 |
| 05/05/2011 | US20110104721 Human ABO Blood Group-Binding Lactobacilli |
| 05/05/2011 | US20110104720 Detection of Analytes Present in Exosomes |
| 05/05/2011 | US20110104719 Methylarginine detection in cells and tissues |
| 05/05/2011 | US20110104718 Analysis of Circulating Tumor Cells, Fragments, and Debris |
| 05/05/2011 | US20110104717 Methods for diagnosis, prognosis and methods of treatment |
| 05/05/2011 | US20110104716 Novel method for screening brain-active compounds |
| 05/05/2011 | US20110104715 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/05/2011 | US20110104714 Non-proteolytic method for the determination of analytes in keratinized structures |
| 05/05/2011 | US20110104713 Products and processes for modulating peptide-peptide binding domain interactions |
| 05/05/2011 | US20110104712 Method for Assaying Plasma Enzymes in Whole Blood |
| 05/05/2011 | US20110104711 GPR81-Ligand complexes and their preparation and use |
| 05/05/2011 | US20110104710 Construction of expression system for rna polymerase derived from influenza virus, crystallization of the rna polymerase, and screening method for anti-influenza agent |
| 05/05/2011 | US20110104709 Porous solid phase for binding assay, and binding assay method using the same |
| 05/05/2011 | US20110104708 Method for Sensing a Chemical |
| 05/05/2011 | US20110104707 Methods and products for diagnosing autoimmune disease and gastric cancer linked with atrophic gastritis |
| 05/05/2011 | US20110104706 Novel kinases and uses thereof |
| 05/05/2011 | US20110104705 Musclin receptor and use thereof |
| 05/05/2011 | US20110104701 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 05/05/2011 | US20110104700 Molecular signature for fibrosis and atrophy |
| 05/05/2011 | US20110104698 Markers for determining dna damage and telomere dysfunction for the determination of the biological age, regenerative capacity, cancer risk, the risk of developing age-related diseases and the prognosis of chronic diseases in humans and animals |
| 05/05/2011 | US20110104697 Methods and compositions for diagnosing and monitoring transplant rejection |
| 05/05/2011 | US20110104695 Methods of predicting therapeutic efficacy of cancer therapy |
| 05/05/2011 | US20110104683 Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome |
| 05/05/2011 | US20110104681 Novel transgene assay using stable agrobacterium rhizogenes transformation |
| 05/05/2011 | US20110104680 Recurrent gene fusions in lung cancer |
| 05/05/2011 | US20110104679 Methods and Compositions for the Diagnosis and Treatment of Angiogenic Disorders |
| 05/05/2011 | US20110104676 Hybridization chain reaction amplification for in situ imaging |
| 05/05/2011 | US20110104675 Methods and Compositions for Diagnosing Carcinomas |
| 05/05/2011 | US20110104673 NUCLEIC ACID SEQUENCES AND METHODS FOR IDENTIFYING COMPOUNDS THAT AFFECT RNA/RNA BINDING PROTEIN INTERACTIONS AND mRNA FUNCTIONALITY |
| 05/05/2011 | US20110104669 Method to predict iris color |
| 05/05/2011 | US20110104664 Biomarkers and methods for determining sensitivity to micortubule-stabilizing agents |
| 05/05/2011 | US20110104657 Method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker |
| 05/05/2011 | US20110104306 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104282 New Therapy of Treatment of the Irritable Bowel Syndrome |
| 05/05/2011 | US20110104261 Remote detection of substance delivery to cells |
| 05/05/2011 | US20110104257 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 05/05/2011 | US20110104190 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 05/05/2011 | US20110104184 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/05/2011 | US20110104183 Use of sip1 as determinant of breast cancer stemness |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104171 EphA4 Polypeptide Having a Novel Activity and Use Thereof |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104154 Single nucleotide polymorphisms and genes associated with age-related macular degeneration |
| 05/05/2011 | US20110104149 SingleC-9 Binding Agents |
| 05/05/2011 | US20110104148 Antibodies to Carcinoembryonic Antigen (CEA), Methods of Making Same, and Uses Thereof |
| 05/05/2011 | US20110104147 Identification of Tumor-Associated Markers for Diagnosis and Therapy |